Calendar

<<  June 2017  >>
MoTuWeThFrSaSu
2930311234
567891011
12131415161718
19202122232425
262728293012
3456789

View posts in large calendar

NMS Labs Announces Crucial New Tool for Impaired Driving Investigation

NMS Labs, a leading international forensic and clinical reference laboratory, announces the branding of its DUID confirmatory testing results report—ProofPOSITIVE®, An NMS Labs Confirmation Report.

Awareness of the extent of involvement of both therapeutic and abused drugs in impaired driving investigations and fatal crashes continues to grow. The technology to complete the investigation, however, is often lacking, with inadequate testing being performed or lack of understanding of the implications of the drug test findings. NMS Labs has announced the release of its new branded drug confirmation test, ProofPOSITIVE®, to provide a targeted, economical solution to identifying the drugs or combinations of drugs that can account for impairment, and clear interpretive advice provided right on the report. Prepared based on a study of the most common drugs encountered in the Drug Recognition Expert (DRE) and Driving Under the Influence of Drugs (DUID) programs nationwide, ProofPOSITIVE® reinforces NMS Labs commitment to the DRE program, and its need for timely, intelligent, targeted, testing that is also economical.

Since not all tests are created equal, choosing a high-quality laboratory, well informed in the area of DUID testing is essential. NMS Labs ISO-level quality from leaders in forensic laboratories accreditation, ABFT and ASCLD-LAB, and it’s internationally recognized experts in DUID provide confidence to investigators that their tests are in the right hands.

The new test was developed by Dr. Barry Logan, nationally recognized for his leadership and contribution to the field of drug impaired driving. Logan explained, “We’ve added key new compounds to this test to reflect our discovery of the latest trends in drug use in vehicle fatalities and arrests. We expect that this will increase drug detection rates in DUID and vehicular crimes cases by about 10%.” In addition, Logan noted that the ProofPOSITIVE® service adds on testing for more exotic drugs in circumstances where the driver’s impairment cannot be accounted for by the initial screening results. NMS Labs experienced court qualified toxicologists review and sign each report, and provide testimony when required.

“We needed to tell our story better, and ProofPOSITIVE® is simply the right message to resonate with those needing a dependable, quality confirmatory report and interpretive advice on the meaning of results in the court setting,” noted Julie Ruth, Sr. Director of Marketing at NMS Labs

The ProofPOSITIVE® confirmation report reflects NMS Labs alignment with National Safety Council’s recent recommendations for DUID drug testing, providing police with the most relevant targeted approach to DUID testing as well as contributing to the growing momentum around the use of oral fluid as an accepted forensic sample in DUID investigations. Additional details can be found on NMS Labs website.